CDIOCardio Diagnostics Holdings...

Nasdaq cardiodiagnosticsinc.com


$ 0.67 $ 0.00 (-0.53 %)    

Friday, 07-Jun-2024 12:56:29 EDT
QQQ $ 462.76 $ -0.41 (-0.09 %)
DIA $ 388.38 $ -0.84 (-0.22 %)
SPY $ 533.54 $ -0.65 (-0.12 %)
TLT $ 91.51 $ -1.71 (-1.83 %)
GLD $ 211.60 $ -7.83 (-3.57 %)
$ 0.6774
$ 0.68
$ 0.00 x 0
$ 0.00 x 0
$ 0.67 - $ 0.68
$ 0.17 - $ 3.56
61,659
na
15.37M
$ 2.76
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-15-2024 03-31-2024 10-Q
2 04-01-2024 12-31-2023 10-K
3 11-13-2023 09-30-2023 10-Q
4 08-14-2023 06-30-2023 10-Q
5 05-15-2023 03-31-2023 10-Q
6 03-31-2023 12-31-2022 10-K
7 11-07-2022 09-30-2022 10-Q
8 08-10-2022 06-30-2022 10-Q
9 05-12-2022 03-31-2022 10-Q
10 03-31-2022 12-31-2021 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 on-june-3-cardio-diagnostics-holdings-got-notice-from-nasdaq-that-is-no-longer-in-compliance-with-nasdaq-listing-rule-5550a2

– SEC Filing

 benchmark-maintains-speculative-buy-on-cardio-diagnostics-hldgs-raises-price-target-to-2

Benchmark analyst Bruce Jackson maintains Cardio Diagnostics Hldgs (NASDAQ:CDIO) with a Speculative Buy and raises the price...

 benchmark-maintains-speculative-buy-on-cardio-diagnostics-hldgs-lowers-price-target-to-135

Benchmark analyst Bruce Jackson maintains Cardio Diagnostics Hldgs (NASDAQ:CDIO) with a Speculative Buy and lowers the price...

 exponential-health-earlier-announced-it-partnered-with-cardio-diagnostics-for-cardiovascular-disease-prevention-in-michigan

Exponential Health, an innovative concierge medicine practice in Michigan, adopts Cardio Diagnostics' AI-driven epigenetic-...

 blackrock-bolsters-wealth-management-arsenal-with-spiderrock-advisors-acquisition-expanding-sma-solutions

BlackRock (NYSE: BLK) to acquire full ownership of SpiderRock Advisors, expanding offerings in customized option overlay strate...

 why-sophia-genetics-shares-are-trading-lower-by-19-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Shares of SOPHiA GENETICS SA (NASDAQ: SOPH) fell sharply during Tuesday’s session after the company reported worse than expect...

 cardio-diagnostics-holdings-inc-announces-us-patent-application-no-17857723-for-compositions-and-methods-for-detecting-predisposition-to-cardiovascular-disease

Company Continues to Build and Expand the Global IP Portfolio of Its One-of-a-Kind TechnologyCardio Diagnostics Holdings, Inc. ...

 cardio-diagnostics-holdings-inc-expands-heartrisk-platform-offering-to-diverse-markets-in-conjunction-with-nationwide-rollout

Transformative Cardiovascular Risk Management Solutions Extend Beyond Traditional Sectors to Include Federal and State Correcti...

Core News & Articles

Agreement is the first introduction of AI-driven epigenetic heart attack risk assessment and coronary heart disease detection t...

Core News & Articles

FDMT: 86% | 4DMT Presents Interim Data From Randomized Phase 2 PRISM Clinical Trial Of Intravitreal 4D-150 Demonstrating Favora...

 cardio-diagnostics-holdings-restor-longevity-clinic-to-offer-cardio-diagnostics-ai-driven-epigenetic-genetic-heart-disease-tests

resTOR to be the first longevity clinic nationwide to offer the Company's blood-based epigenetic-genetic cardiovascular dis...

 cardio-diagnostics-holdings-announces-grant-of-patent-in-india-under-number-484488-titled-a-kit-for-determining-methylation-status-of-a-cpg-dinucleotide-and-a-genotype-of-a-single-nucleotide-polymorphism

The Company's global patent portfolio includes granted patents in the United States, Europe, India, Australia, China and Ho...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION